Corsair Capital Management, L.P. Rockwell Medical, Inc. Transaction History
Corsair Capital Management, L.P.
- $482 Million
- Q3 2025
A detailed history of Corsair Capital Management, L.P. transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Corsair Capital Management, L.P. holds 35,000 shares of RMTI stock, worth $32,550. This represents 0.01% of its overall portfolio holdings.
Number of Shares
35,000
Previous 55,000
36.36%
Holding current value
$32,550
Previous $46,000
10.87%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RMTI
# of Institutions
42Shares Held
3.4MCall Options Held
25.6KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.26 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny562KShares$522,8500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA323KShares$300,5270.0% of portfolio
-
Black Rock Inc. New York, NY219KShares$203,4100.0% of portfolio
-
Gsa Capital Partners LLP London, X0164KShares$152,4990.02% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $9.93M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...